Regenerative Medicine Cellular Treatment

NTL Biologica Cellular Therapy Stem Cell
Home Page background
NTL Biologica Cellular Therapy Stem Cell
CELLULAR
THERAPY OF
THE FUTURE
NTL Biologica Cellular Therapy Stem Cell
CELLULAR
THERAPY OF
THE FUTURE
NTL Biologica Cellular Therapy Stem Cell
CELLULAR
THERAPY OF
THE FUTURE
BIOLOGICAL CELLULAR
TREATMENTS EXPLAINED

Everything you need to know about the latest cutting edge cellular treatment, state of the art equipments for easy extration and our upcoming celular range of products.

BIOLOGICAL
CELLULAR
TREATMENTS
EXPLAINED

Everything you need to know about the latest cutting edge cellular treatment, state of the art equipments for easy extration and our upcoming celular range of products.

NTL Biologica Cellular Therapy Stem Cell
QUALITY
BIOLOGICAL
DEVICES
NTL Biologica Cellular Therapy Stem Cell
INNOVATIVE
THERAPUTICS
AND DIAGNOSTICS
NTL Biologica Cellular Therapy Stem Cell
EVIDENCE
BACKED
STUDIES
NTL Biologica Cellular Therapy Stem Cell
MHRA
APPROVED
QUALITY

QUALITY
BIOLOGICAL
DEVICES

INNOVATIVE
THERAPUTICS
& DIAGNOSTICS

EVIDENCE
BACKED
STUDIES

MHRA
APPROVED
QUALITY

BIOLOGICAL
CELLULAR
TREATMENTS
EXPLAINED

Everything you need to know about the latest cutting edge cellular treatment, state of the art equipments for easy extration and our upcoming celular range of products.

NTL Biologica Cellular Therapy Stem Cell

QUALITY
BIOLOGICAL
DEVICES

NTL Biologica Cellular Therapy Stem Cell

INNOVATIVE
THERAPUTICS
& DIAGNOSTICS

NTL Biologica Cellular Therapy Stem Cell

EVIDENCE
BACKED
STUDIES

NTL Biologica Cellular Therapy Stem Cell

MHRA
APPROVED
QUALITY

A FULLY INTEGRATED CLINICAL ECOSYSTEM FOR THE NEXT GEN CLINIC

Every journey to discovery is unique. We emphasise on your goals and collaborate with you to achieve them. 

NTL Biologica offers solutions to accelerate your regenerative treatments and enhance your approach to maximise your value in the regenerative market.

From autologous stem cell devices for in clinic patient use to allogenic cell lines for implantations and also diagnostics for outpatient services, we are your one stop shop for all things that comes within the regenerative medical space

Slide
Slide
previous arrow
next arrow

A FULLY INTEGRATED CLINICAL ECOSYSTEM FOR THE NEXT GEN CLINIC AND CELLULAR THERAPY

Every journey to discovery is unique. We emphasize on your goals and collaborate with you to achieve them. 

NTL Biologica offers solutions to accelerate your regenerative treatments and enhance your approach to maximise your value in the regenerative market.

From autologous stem cell devices for in clinic patient use to allogenic cell lines for implantations and also diagnostics for outpatient services, we are your one stop shop for all things that comes within the regenerative medical space.

Slide
Slide
previous arrow
next arrow
Slide
WHO WE ARE

NTL Biologica is pioneering the way medical treatments are designed for joint care treatments and the aesthetic market using devices specially designed for autologous regenerative treatments which bring s the concept of using a patient’s own mesenchymal signalling cells to repair damaged tissue, by using the patient's own cells to repair and heal. With its manufacturing set in Korea, NTL Biologica ensure the medical equipments meet the UK standards by conducting trials with Universities and Clinics across the UK.

NTL Biologica is pioneering the way medical treatments are designed for joint care treatments and the aesthetic market using devices specially designed for autologous regenerative treatments which brings the concept of using a patient’s own mesenchymal signalling cells to repair damaged tissue, by using the patient's own cells to repair and heal. With its manufacturing set in Korea, NTL Biologica ensure the medical equipments meet the UK standards by conducting trials with Universities and Clinics across the UK.

NTL Biologica is pioneering the way medical treatments are designed for joint care treatments and the aesthetic market using devices specially designed for autologous regenerative treatments which bring s the concept of using a patient’s own mesenchymal signalling cells to repair damaged tissue, by using the patient's own cells to repair and heal. With its manufacturing set in Korea, NTL Biologica ensure the medical equipment meets the UK standards by conducting trials with Universities and Clinics across the UK.

NTL Biologica is currently establishing it’s way into allogenic cellular therapies using their newly built state of the art laboratory near Portsmouth, UK. This creates a wave of pioneering change both in the public and private healthcare practice. We are looking to transform the way people think about their health and what treatments are available to them.

NTL Biologica is currently establishing it’s way into allogenic cellular therapies using their newly built state of the art laboratory near Portsmouth, UK. This creates a wave of pioneering change both in the public and private healthcare practice. We are looking to transform the way people think about their health and what treatments are available to them.

NTL Biologica is currently establishing it’s way into allogenic cellular therapies using their newly built state of the art laboratory near Portsmouth, UK. This creates a wave of pioneering change both in the public and private healthcare practice. We are looking to transform the way people think about their health and what treatments are available to them.

Regenerative Medicine  Cellular Therapy

Our Social Media Pages

Facebook

LinkedIn